期刊文献+

强力天麻杜仲胶囊联合缬沙坦治疗轻中度原发性高血压疗效观察 被引量:3

下载PDF
导出
摘要 目的:观察强力天麻杜仲胶囊联合缬沙坦治疗轻中度原发性高血压疗效。方法:将80例轻中度原发性高血压患者随机分为联合用药组(40例)和对照组(40例)。联合用药组清晨定时空腹服用缬沙坦80mg,同时服用强力天麻杜仲胶囊3粒,早晚各1次。对照组单用缬沙坦80mg清晨定时空腹顿服。总疗程8周。结果:联合用药组治疗后的血压下降幅度为(19.4±8.1/11.6±5.1)mmHg。对照组治疗后的血压下降幅度为(18.2±4.2/11.1±9.6)mmHg。血压晨峰控制达标率比较:联合用药组(32例)94.1%,对照组(20例)60.6%。两组间有显著性差异(P<0.01)。两组间治疗前后血压下降幅度差异均有统计学意义(P<0.01)。两组间差异无统计学意义(P>0.05)。联合用药组和对照组降压显效率分别为59.0%和60.5%,总有效率分别为87.2%和86.8%,本实验中联合用药组出现不良反应者少。结论:强力天麻杜仲胶囊联合缬沙坦治疗轻中度原发性高血压疗效确切,安全可靠,且血压晨峰控制达标率高。
出处 《中成药》 CAS CSCD 北大核心 2009年第8期1164-1166,共3页 Chinese Traditional Patent Medicine
  • 相关文献

参考文献3

二级参考文献25

  • 1European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens ,2003,21 : 1011-1053.
  • 2Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 2003,42 : 1206-1252.
  • 3Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med ,2001,345 : 1291-1297.
  • 4Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet, 2001, 358: 1305-1315.
  • 5Protogerou AD, Papaioannou TG, Blacher J, et al. Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? J Hypertens,2007,25: 265 -272.
  • 6Williams B, Lacy PS, Thorn SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes : principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation, 2006,113 : 1213-1225.
  • 7Pedersen OL, Mancia G, Pickering T, et al. Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy. J Hypertens, 2007,25:707-712.
  • 8Berl T, Hunsicker LG, Lewis JB,et al. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol, 2005,16:2170-2179.
  • 9Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med ,2006,144 : 884-893.
  • 10Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of ' masked' hypertension and 'white-coat' hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol,2005, 46:508-515.

共引文献24

同被引文献41

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部